BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23140590)

  • 61. Focal liver lesions: sinusoidal phase of CEUS.
    D'Onofrio M; Martone E; Faccioli N; Zamboni G; Malagò R; Mucelli RP
    Abdom Imaging; 2006; 31(5):529-36. PubMed ID: 16802201
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Liver tumor characterization--review of the literature.
    Dietrich CF; Maddalena ME; Cui XW; Schreiber-Dietrich D; Ignee A
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S3-10. PubMed ID: 22723026
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
    J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
    Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
    Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Guidelines for the use of contrast agents in ultrasound. January 2004.
    Albrecht T; Blomley M; Bolondi L; Claudon M; Correas JM; Cosgrove D; Greiner L; Jäger K; Jong ND; Leen E; Lencioni R; Lindsell D; Martegani A; Solbiati L; Thorelius L; Tranquart F; Weskott HP; Whittingham T;
    Ultraschall Med; 2004 Aug; 25(4):249-56. PubMed ID: 15300497
    [No Abstract]   [Full Text] [Related]  

  • 66. Detection of hepatocellular carcinoma and liver metastases with BR14: a multicenter phase IIA study.
    Hohmann J; Müller A; Skrok J; Wolf KJ; Martegani A; Dietrich CF; Albrecht T
    Ultrasound Med Biol; 2012 Mar; 38(3):377-82. PubMed ID: 22261514
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Contrast Enhanced Ultrasound for the evaluation of focal liver lesions in daily practice. A multicentre study.
    Sporea I; Badea R; Martie A; Dumitru E; Ioaniţescu S; Şirli R; Socaciu M; Popescu A; Dănilă M; Voiculescu M
    Med Ultrason; 2012 Jun; 14(2):95-100. PubMed ID: 22675708
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Contrast enhanced ultrasound in focal liver lesions--a cost efficiency study.
    Sirli R; Sporea I; Martie A; Popescu A; Dănilă M
    Med Ultrason; 2010 Dec; 12(4):280-5. PubMed ID: 21210012
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
    Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
    Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Computer-aided diagnosis of focal liver lesions by use of physicians' subjective classification of echogenic patterns in baseline and contrast-enhanced ultrasonography.
    Sugimoto K; Shiraishi J; Moriyasu F; Doi K
    Acad Radiol; 2009 Apr; 16(4):401-11. PubMed ID: 19268851
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
    Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J
    J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Estimation of optoacoustic contrast agent concentration with self-calibration blind logarithmic unmixing.
    Deán-Ben XL; Buehler A; Razansky D; Ntziachristos V
    Phys Med Biol; 2014 Sep; 59(17):4785-97. PubMed ID: 25097086
    [TBL] [Abstract][Full Text] [Related]  

  • 73. AIUM practice guideline for ultrasonography in reproductive medicine.
    ; ;
    J Ultrasound Med; 2009 Jan; 28(1):128-37. PubMed ID: 19106372
    [No Abstract]   [Full Text] [Related]  

  • 74. Contrast material-enhanced abdominal US examinations with DMP 115 (DEFINITY) provides additional diagnostic information with potential for changes in patient management.
    Rosenberg ML; Carpenter AP;
    Acad Radiol; 2002 May; 9 Suppl 1():S243-5. PubMed ID: 12019880
    [No Abstract]   [Full Text] [Related]  

  • 75. [Tracer diagnosis severe injury/polytrauma in key issue paper 2016].
    Schweigkofler U; Flohé S; Hoffmann R; Matthes G; Paffrath T; Wölfl C; Fischer M; Kehrberger E; Marung H; Moecke H; Prückner S; Urban B; Trentzsch H;
    Unfallchirurg; 2016 Nov; 119(11):961-963. PubMed ID: 27757483
    [No Abstract]   [Full Text] [Related]  

  • 76. Guidelines for elastography.
    Popescu A; Sporea I
    Med Ultrason; 2013 Jun; 15(2):83-4. PubMed ID: 23702495
    [No Abstract]   [Full Text] [Related]  

  • 77. [Key issues paper 2016: specific recommendations for tracer diagnoses].
    Trentzsch H; Fischer M; Kehrberger E; Marung H; Moecke H; Prückner S; Urban B;
    Unfallchirurg; 2016 Nov; 119(11):959-960. PubMed ID: 27757486
    [No Abstract]   [Full Text] [Related]  

  • 78. Contrast media and radiopharmaceutical agents: regulatory issues.
    Baum S; Eckelman WC; Garcia EV; Holman BL; Kung HF; Mattrey RF; Piwnica-Worms D; Wahl RL; Watson JT
    Acad Radiol; 1995 Sep; 2 Suppl 2():S92-3. PubMed ID: 9419707
    [No Abstract]   [Full Text] [Related]  

  • 79. [Contrast agents: guidelines at last].
    Clément O;
    J Radiol; 2005 Jun; 86(6 Pt 1):613. PubMed ID: 16142024
    [No Abstract]   [Full Text] [Related]  

  • 80. Non-invasive diagnostic imaging of colorectal liver metastases.
    Mainenti PP; Romano F; Pizzuti L; Segreto S; Storto G; Mannelli L; Imbriaco M; Camera L; Maurea S
    World J Radiol; 2015 Jul; 7(7):157-69. PubMed ID: 26217455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.